How did LEXX's revenue and expenses trend in Q1 2025?
5/9/2025 03:36am
Lexaria Bioscience (LEXX) experienced a significant decline in net income in Q1 2025, with total expenses exceeding revenue, resulting in a negative net income.
1. **Revenue**: The total revenue for LEXX in Q1 2025 was $174,000.
2. **Expenses**: The total expenses were -$2.72 million.
3. **Net Income**: The net income was -$2.54 million.
|code|Ticker|Name|Date|Total Revenue|Total Expenses|Net Income|market_code|
|---|---|---|---|---|---|---|---|
|LEXX|LEXX.O|Lexaria Bioscience|2024 Q2|145000||-652733|186|
|LEXX|LEXX.O|Lexaria Bioscience|2024 Q3|84000||-1784312|186|
|LEXX|LEXX.O|Lexaria Bioscience|2024 Q4|84000||-2186571|186|
|LEXX|LEXX.O|Lexaria Bioscience|2025 Q1|183923||-2706628|186|